What key data have been presented in relapsed/refractory multiple myeloma that you cannot miss from ASH 2021?

Learning objective:

After participating in this webinar, viewers should be able to:

• Discuss the data updates from ASH 2021 on immunotherapeutic approaches for patients with multiple myeloma  

Faculty:

• Maria-Victoria Mateos (Spain)
• Hermann Einsele (Germany)
• Philippe Moreau (France)
• Rakesh Popat (UK)
• Niels van de Donk (Netherlands)